Categories AlphaGraphs, Earnings, Health Care
Infographic: Key highlights of Medtronic (MDT) Q4 2020 earnings results
Medtronic plc (NYSE: MDT) reported its financial results for the quarter ended April 24, 2020, on Thursday before the market opens. The results missed analysts’ expectations.
The company posted a 45% dip in earnings for the fourth quarter of 2020 due to the impact of the COVID-19 pandemic. The results were in-line with the expectations and consistent with the impact felt across the MedTech industry from deferred procedures as a result of the pandemic.
Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.
On May 20, the board of directors approved an increase in cash dividend for the first quarter of fiscal 2021, raising the quarterly amount to $0.58 per ordinary share. The dividend is payable on July 17, 2020, to shareholders of record on June 26, 2020.
Past Performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
